Kewen Li

Dr. Kewen Li


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
ZBZhang Bin-Bin
Zhang Bin-Bin
ZDZha Xi Da-Wa
Zha Xi Da-Wa
LCLi Chao
Li Chao
ZLZhang Lan-Tao
Zhang Lan-Tao
WTWu Tao
Wu Tao
KLKewen Li
Kewen Li
Background: Bone marrow mesenchymal stem cells have always been a heated research topic in bone tissue regeneration and repair because of their self-renewal and multi-differentiation potential. A large number of studies have been focused on finding the inducing factors that will promote the osteogenic differentiation of bone marrow mesenchymal stem cells. Previous studies have shown that macrophage exosomes or miRNA-26a-5p can make it work, but the function of this kind of substance on cell osteogenic differentiation has not been public. Methods: M2 macrophages are obtained from IL-4 polarized bone marrow-derived macrophages. Exosomes were isolated from the supernatant of M2 macrophages and identified via transmission electron microscopy (TEM), western blotting, and DLS. Chondrogenic differentiation potential was detected by Alcian blue staining. Oil red O staining was used to detect the potential for lipogenic differentiation. And MTT would detect the proliferative capacity of cells. Western blot was performed to detect differential expression of osteogenic differentiation-related proteins. Results: The results showed that M2 macrophage exosomes will promote bone differentiation and at the same time inhibit lipid differentiation. In addition, M2 macrophage-derived exosomes have the function of promoting the expression of SOX and Aggrecan suppressing the level of MMP13. The exosome inhibitor GW4689 suppresses miRNA-26a-5p in M2 macrophage exosomes, and the treated exosomes do not play an important role in promoting bone differentiation. Moreover, miRNA-26a-5p can enable to promote bone differentiation and inhibit lipid differentiation. miRNA-26a-5p can promote the expression of ALP (alkaline phosphatase), RUNX-2 (Runt-related transcription factor 2), OPN(osteopontin), and Col-2(collagen type II). Therefore, it is speculated that exosomal miRNA-26a-5p is indispensable in osteogenic differentiation. Conclusions: The present study indicated that M2 macrophage exosomes carrying miRNA-26a-5p can induce osteogenic differentiation of bone marrow-derived stem cells to inhibit lipogenic differentiation, and miRNA-26a-5p will also promote the expression of osteogenic differentiation-related proteins ALP, RUNX-2, OPN, and Col-2.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZDZha Xi Da-Wa
Zha Xi Da-Wa
MJMa Jun
Ma Jun
LCLiu Chao-Zheng
Liu Chao-Zheng
YSYang Sen-Lin
Yang Sen-Lin
LCLu Chuan
Lu Chuan
KLKewen Li
Kewen Li
Macrophages are commonly classified as M1 macrophages or M2 macrophages. M2 macrophages are obtained by stimulation of IL‐4 with anti‐inflammatory and tissue repair effects. Exosomes are 30–150 nm lipid bilayer membrane vesicles derived from most living cells and have a variety of biological functions. Previous studies have shown that macrophage exosomes can influence the course of some autoimmune diseases, but their effect on knee osteoarthritis (KOA) has not been reported. Here, we analyze the roles of exosomes derived from M2 macrophage phenotypes in KOA rats. Exosomes were isolated from the supernatant of M2 macrophages and identified via transmission electron microscopy (TEM), Western blotting, and DLS. The results showed that M2 macrophage exosomes significantly attenuated the inflammatory response and pathological damage of articular cartilage in KOA rats. In addition, a key protein associated with KOA including Aggrecan, Col‐10, SOX6, and Runx2 was significantly increased, while MMP‐13 was significantly suppressed following treatment with M2 macrophage exosomes. The present study indicated that M2 macrophage exosomes exerted protective effects on KOA rats mainly mediated by the PI3K/AKT/mTOR signal pathway. These findings provide a novel approach for the treatment of KOA.

18 September 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
BZBinbin Zhang
Binbin Zhang
BDBin Dou
Bin Dou
KLKewen Li
Kewen Li
Background: Hip fractures attributable to falls (HFAF) represent one of the life-threatening conditions in older adults. This study aims to analyze trends and geographical distribution characteristics of HFAF in older adults from 1990 to 2021.Methods: Key indicators including incidence, prevalence, and years lived with disability (YLDs) were extracted from the Global Burden of Disease (GBD) 2021 database. Spatiotemporal trends in disease burden were systematically described using methods including Joinpoint regression analysis, age-period-cohort analysis, inequality analysis, and frontier analysis. Decomposition analysis was used to explore key factors underlying fluctuations in HFAF burden in older adults. Finally, the ARIMA model was employed to project disease burden over the next 15 years.Result: Globally, from 1990 to 2021, age-standardized prevalence (ASPR) and incidence (ASIR) of HFAF in older adults increased, whereas age-standardized YLDs (ASYR) decreased. Disease burden was greater in regions with higher socioeconomic status. Gender-based analysis showed that disease burden was greater among older women than among older men. Over time, cross-country inequalities widened. Frontier analysis identified that countries such as Belgium and Switzerland have substantial potential to improve disease control. Decomposition analysis identified population growth as the primary driver of the rising global burden. Projections indicated that case numbers will continue to rise by 2036, but age-standardized rates will decline.Conclusion: This study indicates that the global disease burden of HFAF in older adults increased from 1990 to 2021 and is projected to continue rising through 2036. Reductions in ASYR suggest that current treatment measures are effective.

30 November 2025 in Regenerative Therapy
Verified
Journal Article
Open access
BZBinbin Zhang
Binbin Zhang
CLChuan Lu
Chuan Lu
BDBin Dou
Bin Dou
WGWenzuo Gu
Wenzuo Gu
KLKewen Li
Kewen Li
Knee osteoarthritis (KOA) is the most prevalent subtype of arthritis, characterized by progressive degeneration of articular cartilage. The present study aimed to investigate the reparative potential of exosomes derived from hypoxia-preconditioned bone marrow mesenchymal stem cells (Hypo-BMSCs-Exos) in treating cartilage damage associated with KOA. An in vitro KOA chondrocyte model was established through induction with interleukin-1β (IL-1β). Subsequently, the modeled chondrocytes were co-cultured with Hypo-BMSCs-Exos. Flow cytometry, Western blotting, immunofluorescence staining, and senescence-associated β-galactosidase (SA-β-gal) staining were used to evaluate the effects of Hypo-BMSCs-Exos on chondrocyte proliferation, apoptosis, extracellular matrix (ECM) metabolic homeostasis, and cellular senescence. For in vivo assessment of Hypo-BMSCs-Exos efficacy, exosomes were administered to KOA model rats via intra-articular injection. Histological scoring, Micro-CT, pain behavioral assessments, and immunohistochemical analysis were then performed to determine the reparative effects of Hypo-BMSCs-Exos on cartilage damage. Hypo-BMSCs-Exos exerted superior effects in suppressing inflammatory responses, apoptosis, ECM degradation, and cellular senescence in rat chondrocytes. Specifically, treatment with Hypo-BMSCs-Exos upregulated the expression of ECM synthesis-related proteins (Collagen II, aggrecan) while downregulating the expression of ECM degradation-related proteins (ADAMTS-5, MMP-13), pro-inflammatory cytokines (iNOS, COX2), and key senescence-associated proteins (p53, p21, p16). Additionally, a reduction in the number of SA-β-gal-positive senescent chondrocytes was observed. In vivo experiments revealed that intra-articular injection of Hypo-BMSCs-Exos in KOA rats significantly improved the inflammatory microenvironment within the joint, promoted articular cartilage regeneration, and restored the structural integrity of subchondral bone. Furthermore, in vivo findings demonstrated that Hypo-BMSCs-Exos significantly regulated the expression of pain-related molecules and exerted a marked inhibitory effect on pain-related behaviors in KOA rats. Hypo-BMSCs-Exos can effectively alleviate cartilage degeneration and pain in KOA, thus offering a novel and promising cell-free therapeutic strategy for the intervention of KOA.

16 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BZBinbin Zhang
Binbin Zhang
BDBin Dou
Bin Dou
WGWenzuo Gu
Wenzuo Gu
CLChuan Lu
Chuan Lu
QYQi Yan
Qi Yan
KLKewen Li
Kewen Li
Objective: High BMI is a critical risk factor for early-onset OA (diagnosed before age 55). This study aimed to analyze global trends in the age-standardized disability-adjusted life years rates (ASDR) attributable to high BMI from 1990 to 2021. Methods: Data from the Global Burden of Disease 2021 (GBD 2021) study were analyzed to assess early-onset OA attributable to high BMI across 204 countries, 21 GBD regions, and 5 Socio-Demographic Index (SDI) tiers. Temporal trends in ASDR were quantified using the estimated annual percentage change (EAPC) and Joinpoint regression. Age-period-cohort models and decomposition analysis identified drivers of burden, while inequality was assessed using the Slope Index of Inequality (SII) and Concentration Index (CI). ARIMA models projected trends to 2036. Results: The disease burden of early-onset OA attributable to high BMI increased significantly between 1990 and 2021. The DALYs for early-onset knee and hip OA rose by 203.01% and 170.12%, respectively, with average annual percentage changes (AAPC) of 1.39% and 1.40%. The age-period-cohort analysis indicated that DALYs risk increased with age and period, and later birth cohorts experienced a higher burden of early-onset OA attributable to high BMI. Decomposition analysis revealed that population growth was the primary driver of the rising disease burden. There were significant absolute and relative inequalities in the burden of early-onset OA attributable to high BMI, as measured by the SDI. Countries with higher SDI bore a greater burden. The SII demonstrated that the ASDR gap between countries with the highest and lowest SDI widened steadily from 1990 to 2021. Predictive analysis suggested that the burden of early-onset OA attributable to high BMI will continue to increase over the next 15 years. Conclusion: From 1990 to 2021, the global burden of early-onset OA attributable to high BMI showed a consistent upward trend, with significant inequalities across countries. The disease burden is projected to grow further in the future.